EUS-Fiducial Markers Improve Pancreas Surgery Guidance

Researchers conducted a preliminary controlled trial to evaluate the feasibility of using endoscopic ultrasound-guided fiducial markers (EUS-FMP) to guide pancreas surgery. The study enrolled 20 patients with resectable pancreas masses and found that EUS-FMP was successful and technically straightforward before planned surgery. Intraoperative detection of the markers was feasible and improved compared to lesions without a marker. The mean tumor size detected by EUS was 1.7 cm. The study suggests that EUS-FMP can be a useful tool for guiding pancreatic resection.